throbber
23 NEPHROL 2011; 24(01): 106-111
`SLANTNNTTINNNUNNTNNUNNTNTNTTNT
`
`
`
`
`
`
`
`fitemuerubeTREB oo
`BPUAMEAMscnt
`
`me.ge
`6F
`
`
`
`
`
`at ot.
`
`whee
`
`NHS
`
`of sclerotic lesions (18, 19). Adenoviral gene transfer of
`soluble TGF-B1 receptorIl reduced the number of a-SMA
`(+) cells and ameliorated interstitial fibrosis in NTN (20). In
`our study, a-SMA was expressedinitially in the periglom-
`erular area on day 4; however, its periglomerular as well as
`mesangial expression was increased on day6, when the fi-
`bronectin expression wasalso increased. The periglomeru-
`lar o-SMA up-regulation can be attributed to myofibroblast
`formation. Activated myofibroblasts become hypertrophic
`and secrete extracellular matrix proteins, and this may lead
`to glomerulosclerosis, fibrous crescent formation and tubu-
`lointerstitial fibrosis (18).
`Phosphorylation and activation of p88 MAPK was noticed
`very early, only 5 hours after NTS induction, but most inter-
`estingly, its activation happened in a repeated way. P-p38
`MAPK expression was increased 5 hours after induction
`of NTN, reduced to normal levels during days 2-4 and re-
`lapsed on day 6. Transient inactivation of p-p38 MAPK may
`be due to its interaction with MAPK phosphatases (MKPs).
`MKPsare a family of protein phosphatases, which are re-
`sponsible for the dephosphorylation and inactivation of
`MAPKs. MKPsare activated simultaneously with MAPKs
`(20, 21), and they may be responsible for p-p38 MAPKin-
`activation.
`In the present study this inactivation seemed
`to be transient, because p38 MAPK wasreactivated later,
`probably as a result of cytokine and growth factor produc-
`tion. To our knowledge, this dual activation of p38 MAPK
`has not been described previously; however, more specific
`studies are necessary to investigate it further.
`There was only a small reduction in renal p-p38 MAPK ex-
`pression in IL-11-treated rats. These results suggest that
`glomerular expression of TGF-B1 and infiltration/transfor-
`mation of myofibroblasts may proceed independently of
`p-p38 MAPK,this is in accordance with a previous study,
`which showed that p-p38 MAPK was not the only down-
`stream signalling intermediate in the pathway from TGF-B1
`to a-SMA (22). Also, administration of a TGF-B1 receptor
`inhibitor (SD-208) resulted in the attenuation myofibroblast
`transformation of lung fibroblasts, an effect that could not
`be achieved by a p38 MAPKinhibitor(SD 282) (23).
`In our previous report, both high and low doses of IL-11
`reduced proteinuria and glomerular fibrinoid necrosis, but
`had a different effect on glomerular macrophages(10). Dai-
`ly treatment with a high dose (1,360 ug) of rhIL-11 reduced
`the numberofinfiltrating macrophages; a low dose (800
`yg) of rhIL-11 reduced only the numberof activated mac-
`rophages, not the total number of macrophages. Based on
`this reduction, the anti-TGF effect of IL-11 could be attrib-
`uted to its anti-inflammatory properties, a mechanism that
`has also been described for other agents (24). However,
`
`—
`
`weniels
`
`RH
`
`acceding
`
`Fig. 3 - Treatment with rhIL-11 in nephrotoxic nephritis (NTN).
`Treatment with high-dose IL-11 reduced expression of glom-
`erular TGF-81 (A), glomerular «&-SMA (C), periglomerular
`«-SMA (D), glomerular fibronectin (E) and periglomerular
`fibronectin (F) in comparison with vehicle-treated rats. The
`reduction in glomerular p-p38 MAPK(B) wasnotsignificant.
`
`
`
`In this study, we have shown that treatment with a high
`dose of IL-11 reduced glomerular expression of TGF-B1,
`a-SMA and fibronectin in NTN. To our knowledge, the
`present studyis the first demonstration that administration
`of rhIL-11 mayalleviate glomerular expression of TGF-B1
`activation of myofibroblasts and extracellular matrix depo-
`sition in experimental glomerulonephritis.
`In the kidney, myofibroblasts may derive from perivascular
`smooth muscle cells, pericytes and interstitial fibroblasts,
`after stimulation by cytokines such as TGF-$1 and IL-18
`(15-17). Myofibroblasts are implicated in the development
`
`© 2011 Societa Italiana di Nefrologia - SSN 1121-8428
`
`109
`
`Ex. 2001 - Page1544
`Ex. 2001 - Page1544
`
`

`

`Siangou et al: Anti-TGF effect of IL-11 in glomerulonephritis
`SLANTNNTTINNNUNNTNNUNNTNTNTTNT
`
`the fact that low-dose rhIL-11 was enough to reduceIL-
`1B production, and macrophageactivity, but not TGF-B1,
`Qa-SMA and fibronectin expression, makes the position
`more complicated. It seems that administration of rhlL-11
`has the potential to reduce inflammation, even when giv-
`en at lower doses, but this anti-inflammatory effect is not
`enough to justify its anti-TGF effect, which requires higher
`dosage, andis also independent from p38 MAPK dephos-
`phorylation and inactivation. One of the speculations is that
`the reduction in the number of glomerular macrophagesis
`needed to reduce the TGF-81 expression. Further work is
`needed to investigate this possibility.
`Findings of the present study suggest that IL-11 has a
`dose-dependenteffect in glomerular expression of TGF-B1,
`myofibroblast differentiation and extracellular matrix depo-
`sition in NTN. This finding may be of relevance to develop-
`ment of possible new applications of IL-11 and also novel
`treatment strategies in patients with glomerulonephritis.
`
`Financial support: This work was supported by a research project
`grant from Kidney Research UK. M.S. received a research project
`grant from the Greek Renal Association.
`
`Conflict of interest statement: James C. Keith Jr is an employee of
`Wyeth Research, Cambridge, MA, USA.
`
`Address for correspondence:
`Maria Stangou, MD
`Nephrology Department Aristotle University
`Hippokration Hospital
`50 Papanastasiou Street
`Thessaloniki, Greece
`mstangou@math.com
`
`
`
`8.
`
`1.
`
`3.
`
`4.
`
`Trepicchio WL, Dorner AJ. Interleukin-11: a go130 cytokine.
`Ann N Y Acad Sci. 1998;856:12-21.
`2. Miuller-Newen G. The cytokine receptor gp130: faithfully pro-
`miscuous. Sci STKE. 2003;2003:PE40.
`Heinrich PC, Behrmann |, Haan S, Hermanns HM, Muller-
`Newen G, Schaper F. Principles of
`interleukin (IL)-6-
`type cytokine signalling and its regulation. Biochem J.
`2003;374:1-20.
`Schwertschlag US, Trepicchio WL, Dykstra KH, Keith JC,
`Turner KJ, Dorner AJ. Hematopoietic,
`immunomodula-
`tory and epithelial effects of
`interleukin-11. Leukemia.
`1999;13:1307-1315.
`Kurzrock R, Cortes J, Thomas DA,Jeha §S,Pilat S, Talpaz M.
`Pilot study of low-dose interleukin-11 in patients with bone
`marrow failure. J Clin Oncol. 2001;19:4165-4172.
` Ragni MV, Jankowitz RC, Chapman HL, et al. A phase Il
`prospective open-label escalating dose trial of recombinant
`interleukin-11 in mild von Willebrand disease. Haemophilia.
`2008;14:968-977.
`Schmitz B, Thiele J, Witte O, Kaufmann R, WickenhauserC,
`FischerR. Influence of cytokines(IL-1 alpha, IL-3, IL-11, GM-
`CSF) on megakaryocyte-fibroblast interactions in normal hu-
`
`5.
`
`6.
`
`7.
`
`man bone marrow. Eur J Haematol. 1995;55:24-32.
`Peterson RL, Wang L, Albert L, Keith JC Jr, Dorner AJ. Mo-
`lecular effects of recombinant human interleukin-11 in the
`
`9.
`
`10.
`
`11.
`
`HLA-B27 rat model of inflammatory bowel disease. Lab |n-
`vest. 1998;78:1503-1512.
`Tang W, Geba GP, Zheng T,et al. Targeted expression of IL-
`11 in the murine airway causes lymphocytic inflammation,
`bronchial remodeling, and airways obstruction. J Clin Invest.
`1996;98:2845-2853.
`Lai PC, Cook HT, Smith J, Keith JC Jr, Pusey CD, Tam FW.
`Interleukin-11 attenuates nephrotoxic nephritis in Wistar
`Kyoto rats. J Am Soc Nephrol. 2001;12:2310-2320.
`Lai PC, Smith J, Bhangal G, et al. Intedeukin-11 reduces
`renal
`injury and glomerular NF-kappa B activity in murine
`experimental glomerulonephritis. Nephron Exp Nephrol.
`2005;101:146-154.
`12. Tam FW, Smith J, Morel D, et al. Development of scarring
`and renal failure in a rat model of crescentic glomerulone-
`phritis. Nephrol Dial Transplant. 1999;14:1658-1666.
`13. Martin MM, BuckenbergerJA,Jiang J, et al. TGF-beta’ stim-
`ulates human AT1 receptor expression in lung fibroblasts by
`cross talk between the Smad, p38 MAPK, JNK, and PI3K
`signaling pathways. Am J Physiol Lung Cell Mol Physiol.
`2007;293:790-799.
`14. Kutz SM, Hordines J, McKeown-Longo PJ, Higgins PJ. TGF-
`
`110
`
`© 2011 Societa Italiana di Nefrologia - SSN 1121-8428
`
`Ex. 2001 - Page1545
`Ex. 2001 - Page1545
`
`

`

`23 NEPHROL 2011; 24(01): 106-111
`SLANTNNTTINNNUNNTNNUNNTNTNTTNT
`
`15.
`
`16.
`
`17.
`
`18.
`
`19.
`
`20.
`
`B1-induced PAI-1 gene expression requires MEKactivity and
`cell-to-substrate achesion. J Cell Sci. 2001;114:3905-3914.
`Vesey DA, Cheung CW, Cuttle L, Endre ZA, Gobe G, Johnson
`DW.Interleukin-1 beta induces human proximaltubule cell in-
`jury, alpha-smooth muscle actin expression and fibronectin
`production. Kidney Int. 2002;62:31-40.
`Kondo S, Kagami S, Urushihara M, et al. Transforming growth
`factor-beta stimulates collagen matrix remodeling through
`increased adhesive and contractive potential by human renal
`fibroblasts. Biochim Biophys Acta. 2004;1693:91-100.
`Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R.
`Fibroblasts in kidney fibrosis emerge via endothelial-to-mesen-
`chymaltransition. J Am Soc Nephrol. 2008;19:2282-2287.
`Goumenos D, Tsomi K, latrou C, et al. Myofibroblasts and
`the progression of crescentic glomerulanephritis. Nephrol
`Dial Transplant. 1998;13:1652-1661.
`Roberts IS, Burrows C, Shanks JH, Venning M, McWilliam
`LJ. Interstitial myofibroblasts: predictors of progression in
`membranous nephropathy. J Clin Pathol. 1997;50:123-127.
`Zhou A, Ueno H, Shimomura M, et al. Blockade of TGF-beta
`action ameliorates renal dysfunction and histologic progres-
`sion in anti-GBM nephritis. Kidney Int. 2003;64:92-101.
`
`21.
`
`22.
`
`23.
`
`24.
`
`Dickinson RJ, Keyse SM. Diverse physiological functions
`for dual-specificity MAP kinase phosphatases. J Cell Sci.
`2006;119:4607-4615.
`Ding Q, Gladson CL, Wu H, Hayasaka H, Olman MA. Fo-
`cal adhesion kinase (FAK)-related non-kinase inhibits
`myofibroblast differentiation through differential MAPK
`activation in a FAK-dependent manner. J Biol Chem.
`2008;283:26839-26849.
`Kapoun AM, Gaspar NJ, Wang Y, et al. Transforming growth
`factor-beta receptor type 1 (TGFbetaRI) kinase activity but
`not p38 activation is required for TGFbetaRl-induced myofi-
`broblast differentiation and profibrotic gene expression. Mol
`Pharmacol. 2006;70:51 8-531.
`Nagatoya K, Moriyama T, Kawada N, et al. Y-27632 prevents
`tubulointerstitial fiprosis in mouse kidneys with unilateral ure-
`teral obstruction. Kidney Int. 2002;61:1684-1695.
`
`Received: July 14, 2009
`Revised: February 22, 2010
`Accepted: March 07, 2070
`
`© 2011 Societa Italiana di Nefrologia - SSN 1121-8428
`
`111
`
`Ex. 2001 - Page1546
`Ex. 2001 - Page1546
`
`

`

`THE JOURNAL OF Bi
`
`
`© 1998cy The Americ bermistry and Molecular Biology, Ine
`
`3, L9DS
`Vol. 273, No. 1U, Iseue of March 6, pp. 550Printed ii
`
`ELSA,
`
`
`Transforming Growth Factor-—8 Stimulates Interleukin-11
`Transcription via Complex Activating Protein-1-dependent
`Pathways*
`
`(Received for publication, September 99, 1997, and in revised form, December 15, 1997}
`
`Weiliang Tangt, Liu Yang$, Yu-Chung Yangs, Shawn X. Lengt, and Jack A. Eliasi?
`Thus;
`
`Fromthe +
`ection ofPulmonary and Critical Care Medicine,
`Ya
`ty Schooi of Medicine, Department of Internal
`
`
`
`t 06520-8087 and SIndiana Unin
`sity School of Medicine, Departments of Medicine
`Medicine, New Haven, Connec
`(Hematology / Oncology), and Biochemistry /Molecular Biology, Walthe:
`7 Oncology Center, Indianapolis, Indiana 46202
`
`Studies were undertaken to characterize the mecha-
`nism by which transforming growth factor-§, (TGR-§,)
`stimulates epithelial cell interleukin (0L)-11 production.
`Nuclear run-on studies demonstrated that TGF-6, is a
`potent stimulator of DL-11 gene transcription. ToE-6,
`also stimulated the luciferase activity in cells trans-
`fected with reporter gene constructs containing mucle-
`otides -728 to +58 of the 0-11 promoter. Studies with
`progressive 5° deletion constructs and site-specific mu-
`tations domonstrated that this stimulation was depend-
`ent on 2 AP-.] sites between nucieotides —10G and —82 in
`the [L-11 promoter. Mobility shift assays demonstrated
`that TGR-8, stimulated AP-1 protein-DNA binding to
`both AP-1 sites. Supershifé analysis demonstrated that
`JunD was the major moiety contributing to AP-1-DNA
`binding im unstimulated cells and that ec-Jun-, Fra-1l-,
`and Fra-2-DNWA binding were increased whereas dhunD-
`DNA binding was decreased in TGF-6,-stimulated cells.
`The sequence in the UL-11 promoter that contains the
`AP-} sites also conferred TGE-8, responsiveness, in a
`position-independent fashion, om a heterologous mini-
`mal promoter. Thus, TGE-6, stimulates IL-11 gene tran-
`scription via a complex AP.l-dependent pathway that is
`dependent on 2 AP-1 motifs betweenmucleotides —106
`and -82 that fumetion as an enhancer in the IL-1}
`promoter.
`
`Interleukin-11 (L-11)' wasoriginaliy discovered as a solubie
`factor in supernatants from transformed stromal cells that
`stimulated plasmacytoma cell proliferation (1). It has subse-
`quentiy been shown to be a pleiotropic memberofthe I-6-type
`cytokine family that mediates
`its biologic activities via binding
`
`
`
`to a multimeric receptor complex that contains the gp13a0 mel-
`ecule (2-5). Among its many effects are the ability te regulate
`hematopoiesis, stimulate the production of acute phase pro-
`
`teins, induce thetis:
`ibitor of metalloproteinase-1, regu-
`
`
`* This work was supported by National Institutes of Health Grants
`
`FIL-36708, AT-34958, AL-54989, HL-56589
`(to F. A.B), DK-50576, and
`HAL-48819 (to Y.-C. ¥.). The casts of publication of this article were
`
`
`defrayed in part by the payment of page charges. Th
`rticle must
`
`therefore be hereby marked “advertisement” in accardance with 18
`
`U.S.C. Section 1734 solely to indicate this fact.
`{To whomcorrespondence should be addressed: Section of Pulme-
`
`
`nary and Critical Care Medicine, Yale University School of Medicine.
`
`
`
`Dept. of Internal Medicine, 353 Cedar St/105 LCI, New Haven, CT
`
`
`0652
`Tel: 208-
`5A183: Fax: 208-785-3826; E-mail:
`jack.
`chas@yals.edua.
`TOF-f,, transforming
`1 The abbreviations used are: UL, interleukin;
`
`
`
`
`
`prowth factor-8,; AP-1, activating protein-1; RSV, respiratory syncytial
`
`
`virus; DMEM, Dulbecco's modified Ragle’s medium; DTT, dithiathre-
`tho EMSA, electrophoretic mobility shift assays; bp, base pais
`
`thymidine kinase.
`
`late bone metabehsm, and alter epithelial proliferation (2,
`6—10). Studies from our laboratcries and others have also dem-
`onstrated that TL-11 can induce tissuefibrosis, regulate tissue
`myocyte and myofibroblast accumulation, alter airway physi-
`ology, and confer protection in the context of mucosal injury o!
`the respiratory and gastrointestinal tracts (11-14).
`tn keeping with the biologic importance of [L-11, a number of
`investigators have studied its sites of production and the reg-
`ulation of these responses. These studies demonstrated that
`
`IL-11 is produced by a variety of stromal cells in
`response to a
`varicty of stimuli, inchading cytokines, histarine, cosinephil
`AE
`
`major basic protein, and r piratory tropic viruses (7, 15-20). A
`
`prominent finding in our studies offibroblasts (18), epithelial
`eclls (19). and osteoblasts (20) and studies by others of chon-
`drocytes and synoviocytes (7) has been the importance of
`TGEF-8 moieties in the stimulation of IL-11 production. These
`studies also demonstrated that TGF-8, stimulation of IL-11
`
`protein production is associated with proportionate changes in
`IL-1] mRNA accumulation and,
`in our studies, IL-1] pene
`transcription (18).
`The IL-11 promoter has been cloned and the cis-elements
`and trans-acting factors that regulate the levels of basal TL-11
`production have been identified by cur laboratories (21). De-
`spite the demonstrated importance of gene transcription in the
`stimulation of IL-l) production, the cis-elements and trans-
`acting factors that mediate the transcriptional activation of
`TL-Li have not been investigated. To further our understand-
`ing of the regulation of IL-11, studies were undertaken to
`
`
`
`characterize the transcriptional elements utilized by TOP-6, in
`stimulation of IL-11. These studies identify twe activating
`n-1 (AP-1) motifs between —100 and —82 in the [1-11
`promoterthat are essential for TGF-g-induced IL-1] transcrip-
`
`tional activation. They also demonstrate that this stimulation
`is associated with camplex alterations in the composition of the
`AP-1 subunits that bind to these sites and that DNA which
`contains these AP-1 elements confers TGR-6, responsiveness
`on a heterologous promoter. Lastly they demonstrate that this
`mechanism is stimulus-specific since respiratory syncytial vi-
`rus (RSV) stimulates TL-11 transcription via a different
`mechanism.
`
`
`
`EXPERIMENTAL PROCEDURES
`
`Celi Culture and TGF-8, Stimulation
`
`A549 human alveolar epithelial-like cells were obtained from the
`American Type Oulture Collection (ATCC, Rockville, MD) and grownto
`
`
`confluence in Dulbecco’s modified Hagle’s medium (DMEM) supple-
`mented with 10% fetal hovine serum (22). Ai confluence, varying can-
`
`
`
`centralions of recombinant human TGP-6,
`(1-10 ng/ml) (Rh & D Sy
`
`
`tems, Minneapolis) or mediurs controls were
`added, and the«
`
`incubated for up to 48 bh. At the desired poinis in time, superr
`
`
`were removed and stered at —20°C, and nuc
`c harves
`further usage (see below).
`
`This paper is available on line at bitp://www.jbc.org
`
`Ex. 2001 - Page1547
`Ex. 2001 - Page1547
`
`
`
`deyWoypapeopumoc]
`
`
`
`
`
`
`
`SIOZ‘T]JOquisaaoNUoABOpOTg[2D[OFXISU]2
`
`

`

`t R
`
`
`
`
`
`TGE-8 Stumulates 4-11 Transcription
`eu
`The DNA fragments with the various 5’ deletions were then se
`
`by electrophoresis, electroeluted, and lpated into BaomHT/Xhol-
`
`linearized pXP2-luc vector. Clones from the subsequent transformation
`
`
`were sercened for insert
`siac, and DNA sequcneing was used to vorify
`junction sequences for all clones that were chosen for further
`utilization.
`
`5, a series of con-
`Through the combined efforts of bath approach
`
`728 to -8L. In
`structs were prepared whose 5’ ends extended from
`
`
`
`all cases, the 3' end was +58 relative to the tra
`ription initiation
`site.
`
`Site-directed Mutagenesis
`Mutation of the AP-1 sites in the parent [L-11 promoter was per-
`
`
`
`formed using the Muta-Gene M43 In Vitre Mutage
`Kat Bio-Rad,
`
`
`catalog number 170-3580) based an Kunkel’s method (29, 40). The
`$82-bp BomHVXhol fragment of Th-11 promoter was excised frors
`
`
`pXP2-1L-11-324 and subcloned into M13 phage. The recombinant pha
`
`BNA was then transformed into bacterial
`
`strain Escherichia coli CS236
`{dut-, ung—, thi-, and relA—) to generate uracil-containing single-
`stranded DNA. Such single-stranded DNA was allowed to anneal to
`
`mutagenic primer, and second strand DNA was synthesized with T7
`
`
`
`DNA palys
`and Ta DNA ligase. When transformedints bacterial
`strain MV1190(dut+, ung+), uracil-containiny single-stranded DNA
`
`
`template was degraded, and only newly synthesized mutation-bearing
`second strand DNAwould propagate. The wild type and mutated AP-1
`
`
`
`sequences are as follows: wild type &’ (distal) AP-1, 5 TGAGTC!
`:
`
`
`
`mutated 5’ (distal) AP-L, 5'-TGAcgaA-2'; wild type 3’ (pveximal) AP-1,
`
`5 -TGTGTCA-3'; mutated 3) (oraximal) AP-1, 5/-TGPepa d-8”. All ofthe
`AP-1 mutation constructs underwent DNA sequencing to verify the site
`and axtent of the induced alterations.
`
`
`Preparation of I.-C tikuc Constructs
`
`A 156-bp BamHT/Xhol fragment from the herp
`mplox virus thy-
`midine kinase (dk) minimal promoter/chioramphenicol acetyltrans-
`ferase reporter gene construct ptk~CAT (81) was obtained from Dr.
`
`Asuradha Ray (Yal
`siversity, New
`and subcloned inio the
`
`
`BamHl and Xhol
`of the pXP2-luc reporter pene construct
`to
`
`
`generate ptk-XP2.
`i
`cleotides (5'-GAT CCG AGG GTG AGT
`
`CAG GAT GTG TCA GGC CGA AGCTT-3' and 5'-GAT CAA GCT TCG
`
`
`
`
`GCC TGA CAC CTG ACT CAC CCT €G-3")
`were then synthesized and
`
`annealed to forra a 38-bp DNA duplex with sticky ends cormpatible witt
`the Bamlil site (' of herpes simplex virus th promoter) in ptk-XP2.
`This insert contaiis a 27-bp DNA sequence of the IL-1) promoter
`63
`
`
`ta -77 relative to ranseriptia start site) that contains both the 5’ and
`
` PS in the correct ((sense! (pILsisC++ the.XP) and reverse(ant
`Nor
`=<j
`35
`
`(pIL1(—)tk-XP2) directions. DNA sequencing was perforrsed to veri
`the sequence and orientation of DIVA insertion.
`
`Cell Transfection and Reporter Gene Assay
`
`A549 cells were seeded at, 40-05 confluence and incubated aver-
`
`
`nipht in DMEMwith
`high elucose and 10% fetal bovine serum. Trans-
`
`
`
`feetions were performed using the DEAE-dextran method as described
`proviously by our laboratory (22). Thecells were then incubated for 24h
`
`
`
`
`in
`serum-free DMEMalone or in DMEMsupyplemented with TGP-#, (10
`
`
`nefmb. In experiments where RSV was util
`d the A549 cells were
`
`incuhated for 90 mis with RSV Gnultiplic
`shiom = 8) or appra-
`priate medium control, washed, and then incubated for 24 h in serum-
`free DMEM. At the endof these incubations, cell lysates weve prepared,
`and luciferase activity was assessed on a Lumat luminometer using the
`
`Luciferase Assay System from Promega (Madison, WI
`
`
`tions the construct pOMY-&-gal (CLONTECH, Palo Alto, CA) was als
`included to contre! for transfection efficiency. The @-galactosidase ac-
`
`
`tivity in uostivulated and stimulated cell Iysaies was characterised
`
`
`
`using the CPRGmethod as descrihed previously in
`2)this laboratory (2%
`
`
` re
`e
`
`The G.galactosidase levels were then used te standardize the me
`ments of luciferase activity.
`
`Jc
`
`Rlectrophoretic Mobility Shift Assay (EMSA}
`
`
`Preparation of Nuclear Extracts--Nuciear extracts were prepared
`
`
`
`
`ing modifications of the
`techniques of Schreiberet ai. (82). Unstimu-
`
`lated, TOP-A,-stimulated, and RSV-infected A549 ces were prepared
`as noted above. At the desired points in time, the cells (107 per condi-
`tion) were mechanically detached, suspended in Tris-buffered saline
`
`freshly supplemented with protease inhibitors (1 uwe/ml leupeptin, 5
`ue/ml aprotinin, and 1 mM phenylracthylsulfonyl fluoride), pelicted at
`4°C, and resuspended, and swollen in solution A (10 mm HEPES, pH
`
`Ex. 2001 - Page1548
`Ex. 2001 - Page1548
`
`Nuclear Run-on Assay
`
`ve rates of genetranscription were assessed using mod
`
`
`
`
`
`xed by our laboratory (22-25).
`cations of protocols previously d
`A549 cells were incubated for 16 h under contral conditions, with
`TGF-g, (10
`ml), or after infection with respiratory syncyvial virus
`
`(RSV) at a multiplicity of infection of 8 as described previously (17-19).
`The eells (8 X 107 per condition) were then washed twice with ice-cold
`uspended in t
`uffer (16
`
`ram Tris-HC}, pH 24, 8 ron Meth, 2mm CaCh, 3 um dithbiothreite!
`
`
`(DPT), 300 mma sucrose, 0.5% Triton K-100). The nuclei were then
`harvested by centrifugation and resuspended tn 100 ul of storage buffer
`(50 mMTris-HCl pH 8.4, 5 wm MeCl, 0.1 mm EDTA, 40%slyceral) and
`stored at -80°C until farther utilized. Nylon membranes were pre-
`
`pared carrying 20 yg each of isolated cDNA fragments encoding Tl-11
`(a gift of De. Paul Schendel, GenetiesInstitute, Cambridge, MA) and
`pUCI1& without a cDNA i
`
`using a slot-blotting apparatus
`¢MINT.FEFOLDTr Schleic ser &Schue
`
`
`and baked in a vacuum oven (80°C for 2h). When ready,
`nuclei were
`
`thawed on ice and pelleted in a microcentrifuge at 4 °C
`30 s, and in
`vitro transeription and RNA labeling were earried out in transeription
`
`buffer (20 mm Tris-HCI, pH 8.3, 100 mM KCI, 4.5 mM MeCl,, 2mm DTT,
`and 400 um each of ATP, OTP, and CTP) in the presence of 200 pCi of
`la"@PLUTP (-3000 Ciummel, Amersham Corp.) and 20% ptyc
`
`
`t
`80 °C for 80 rain. TI
`ction was
`followed with a cold
`ch
`
`of 100 mv UTP for 10 rin at 86 °C. The reaction was then terminal
`
`by incubatingwith stop buffer (50 mm Tris-HICL pH §3, 500 mu Nac,
`5 mM EDTA) with 200 us/ml RNase-free DNase I and 750 unites
`RNasin (Bochringer Mansheim) at 20°C for 145 min. RNA was ox-
`
`
`tracted with phenol/chicreform, precipitated, and washed
`3 alcohol.
`
`Dried RNA pellets were dissolved in equal volurnes of TE buffer
`(0 mm
`Tris-HCl] and TimEDTA, pH 7.8), and radiaactivity was detarmined by
`
`
`
`the mean of duplicate countings of 1-1 aliquots.
`Hybridization was
`performed by incubating each membrane with equal numbers of counts
`of radiolabeled RNA. The membranes were then washed at high strin-
`
`gency, and binding was cvaluatcd using autoradiography.
`
`
`Primer Extension Analy,
`
`A549 cells were incubated for 16 h with TGF-f8, (10 ng/m). T
`supernatant
`e then removed, and poly(A)” RNA was
`isolated using
`
`
`
`ohge(dT) affinity based methodolngy as deserthed (26, 27). Primer ex-
`
`tension was ther
`ing a radiolabeled 20-h
`complemen-
`
`
`
`tary synthetic oligonucleotide corresponding to oligonucleotides -11 to
`
`
`+9 with respect to
`the tran
`ion start site. The 5’ end ofthe resulting
`
`TL-1 mRNA was defined using the Molency murine leukersia virus
`
`primer extension systen (Promega, Madison, WD as described by th
`manutacturer. In this system the 5’ end-labeled oligonucleotide hybrid-
`
`
`ized with the TL-11 mRNAand was utilized as a primer by the Moloney
`murine leukemia virus reverse transcriptase which, in the presence of
`deoxymuclestides, synthesized cDNA until the 5’ end of the mRNA was
`reached. The extended product was then resolved on an 8% uraal
`
`
`polyaerviamide sequencing gel along with a known DNA sequence
`ladder.
`
`Plasmid Construction
`
`A 786-bp Poul! fragment of the human IL-1] promoter was previ-
`ousty isolated and cloned in our lahoratovies (21). This promoter frag-
`ment contained
`uences between —728 and +58 relative to the
`
`transcription start site defined above. It was cloned into the Smalsite
`
`of the huciferase reporter gene vector pXP2-lue (ATCC) to generate the
`construct oXP2-IL-11-7%
`
`Preparation of 5’ Deletion Constructs
`
`
`
`Two techniques were used to ger
`ea series at 5’ deletions of the
`pxP2-1h-11-7528 parent construct. When appropriate restriction sites
`
`m mutants. This
`were present, they were util
`
`
`approach was utilized with the Aca
`the HinfT site ai
`
`- 96. In both cases, the — 728 to +88 fragment of the TL-11 premoter
`was subjected to enzyr
`the desired fragment was re-
`
`cloned inte the vector pRP2-luc using standard approaches. When ap-
`
`propriate restriction sites were net available Bal-31 exonuclease diges-
`
`tion was employed to introduce
`etiens. This technique takes
`advantage ofthe fact. that, Bal-21 degrades bath the 5’ and 8’ ends af
`
`double-stranded DNA without insertinginternal cleavages
`(28). Briefly,
`Bamlil-linearized parent construct pXP2-TL-11-324 was incubated
`with Bal-31 exonuclease for varying periods. BamHI linkers (New
`England Biolabs, cataloguc number 1071, Beverly, MA) were then
`added, and the DNA was subjected to BamHUXkhol double digestion
`
`9°
`
`xa8aQa dBB
`
`e
`
`
`
`
`
`SIOZ‘T]JOquisaaoNUoABOpOTg[2D[OFXISU]2
`
`

`

`5508
`
`incubation Conditions
`
`pUG
`
`}
`
`1-41
`
`TGF-68 Stimulates IL-Ii Transcription
`
`79,10 mu KCl, 0.l mm EDTA, 6.1 mm EGTA, 1 mv DTT with freshly
`added protease
`inhibitors as above)
`for 15 min on ice. Membrane lysis
`
`
`
`
`
`xccomplished by adding 25 ul of Nonidet P-40 followed by vigorous
`
`
`
`
`
`agitation. The nuclei were collected by eontrifugation, resuspended im
`59 yl of solution B (20 mM HEPES, pH 7.9, 400 mu NaCl, 1 mm EDTA,
`imM EGTA, 1 mm DTT and freshly added proteaseinhibiters as above),
`and agitated vigerously at 4°C for 15 min. The membrane debris was
`discarded, and the nuclear extracts were snap-frozen in small aliguots
`and stored at —80 °C.
`rotein concentrations of the nuclear extracts
`
`were determined using the DC Protein Assay System (Bio-Rad).
`i
`probes
`
`were used in these experiments. For the sake of simplicity, only the top
`
`strand DNA sequences are dlustrated here. Four olhgonucleatide probes
`
`were syoth
`ed using the oligonuclestide synt!
`liv at Yale
`
`
`
`University. They include the following: (i) wild type 6’ AP-1 sequence in
`the IL-1L promoter(5’ AP-1D (5'-GGGAGGGTGAGTCAGGATGTG-3’);
`
`(i) mutated 5 AP-1 (6-GGGAGGGTGAcgsAGGATGTG-3); Gi) wild
`type 3’ AP-1 sequence in the TL-11 promoter (6' AP-1) (5’-AGTCAGG-
`ATGTGTCAGGCCGGCCC-3'); and (iv) mutated 3’ AP-1 (5’-AGTCAG-
`
`GATGTcea AGGCCGGCCE.3)).
`Four other cligonucleotides ware obtained from conmercial sources
`(Stratagene, La Jolla, CA). They
`included the following: G) a classic
`
`
`AP-1 oligonucleotide (5'-CTAGTGATGAGTCAGCCGGATC-3"); GD an
`AP-2 oligonucleotide (5/-GATCGAACTGACCGCCCGCGGCCOCET-3).
`Gi) an AP-3 cligonuclectide (6'-CTAGTGGGACTTTCCACAGATC-3"),
`and Gv! as SP-1 oligonacleatide G' -GATCGATCQGGGCGGEGCGAT-
`C39.
`
`
`Ele
`straphoresis—EMSAs were performed using the techniques of
`
`
`y ef af.
`(32). Radiolabeled double-stranded cliponucleotide
`Se
`probes were prepared by annealing complementary oligonucleotides
`
`and ond-labcling using [y“*PIATP and T4 polynuclestide kinase (New
`England Biolabs). The laheled probes were purified by push-column
`chromatography, diluted with TE buffer (10 mMTris-TICl, pil 8.0, 1 mm
`EDTA) to the desired concentralion, and incubated with equal aliguots
`of nuclear extract (2-5 ug) and 2 ugof poly idl-dC}-polyidi-dC! in a total
`volume of 20 yl at room temperature for 1h. Resolution was accom-~
`
`plished by electropheresing 10 ul of the reaction solution on vertical 6%
`
`native polyacrylamide gels containing 2% elycerol using
`45% TRE
`
`buffer (28.5 mm Tris-HCl, 22.2 mmboric acid, (.25 mm EDTA, 5H 8.0).
`Binding was assessed via autoradiopraphy.
`Supershifi EMSA-—-Supershifi assays were used te determine which
`members of the AP-1 family were involved in TGF,-stimulation of
`
`TL-11 gene transcription. In tl
`studies EMSA were performed as
`desevibed above except tt
`sotype matched rabbit polyclonal antibod-
`
`
`ies against AP-1 proteins or contral preimmune antiserum were in-
`
`
`cluded during the 1-h radiclabeled probe-extract incubation period. All
`of the antibodies that were used were purchased from Sania Crox
`Biotechnology (Santa Cruz, CA). They included antibodies that react
`with all Jun family members (Pan-Jun) (catalogue number SC-44X),
`
`JTunB (catalopue oumber 46%), JunD (catalopue number SC-74X), c-Jun
`
` cr SC&22X): all Fos fa
`(catalogue nu
`2
`y members (pan-Pos) (cata-
`
`logue number SC-254X), ¢-Fos {catalogue number SC-52%), FosB (cat-
`
`alogue number 5U-48X), Pra-1
`(catalogue number 50-605X), and Pra-2
`(catalogue number SC604X).
`
`
`
`dyewoypepeojumog
`
`
`
`2a
`55ao\
`<22
`Oa
`m=
`2=
`
`=o
`
`2&g5 Z
`
`z°4
`2BaoOa=
`wOo=
`wn
`
`7y
`
`Fig. 1. Demonstration of the effects of TOP-2, aud RSV on
`IL-1 gene transeription. A549ce
`‘incubated in medium alone
`
`(Control), stinvalated with TGF-;
`PPf) (10 nefinl), ar infected with
`
`
`RSV. Twenty four hours later their nuclei were
`harvested, and gene
`transcription was assessed as deseribed under “Experimental Proce-
`dures
`ne fevels of TL-11 gene transcription are campared with tho
`
`hybridization noted with pUC18 @UC) without a cDNA insort which
`served as a negative control.
`
`Characterization of the Transcription Start Site in the 11-11
`
`
`
`Promoter-—Prior to initiating studies designed to define the
`stimulation-respensive cis-eclements in the HTL-11 promoter,
`
`primer extension analysis was used te characterize the tran-
`
`scription initiation site in TGP-8,-stimulated A549 cells. A
`
`single transcription initiation site was detected. This start site
`was 154 bp upstream of the ATG (data not shown) and is within
`i-2 bases of the start site previously described in unstimulated
`PU-24 primate bone marrow fibroblasts by our laboratories
`(20),
`TGFP-8, Stimulates IL-11 Promoter Activity—To begin to
`characterize the mechanism by which TGH-6, stimulates IL-1
`gene transcription, transient transfection assays were per-
`formed with a promoter-luciferase reporter gene construct con-
`
`taining IL-1L1 promoter elements between nuclectides
`7285
`
`
`and +58 (relative to the transcription start site), The levels of
`luciferase activity in A549 cells were evaluatedat base line and
`after TGFR-8, stimulation. As can be seen in Fig. 2, only a
`modest level of luciferase achivity was able te be detected in
`unstimulated A549 cells. In contrast, TGF-8, was an impres-
`sive, dose-dependent stimulator of the promoter activity of this
`construct (ig. 2). This demonstrates that the -728 to +58
`5
`&
`1
`oy
`fragment
`of the TL-11 promoter contains TGE-8,-responsive
`sequences.
`Previous studies from our laboratory dersonstrated that
`RSValso stimulates A549 cell IL-1L production and mRNA
`
`accumulation (17, 19). The studies noted above demonstrate
`that this stimulation is, at least in part, transeriptionally
`mediated. To determineif the cis-elements in the [L-11 pro-
`moter that respond to TGH-B, alsa respond to RSV, we com-
`
`pared the ability of these twostimuli to stimulate the —728 to
`+58 EL-1l1 promoter-lucifer

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket